Obesity and contraception

Obesity and Adolescence: A Public Health Concern

Volumn , Issue , 2009, Pages 74-84

  Greydanus, Donald E ^a   Omar, Hatim A ^b   Tsitsika, Artemis K ^c  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84896214064     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (40)

1. Greydanus DE, Patel DR, Rimsza ME. Contraception in the adolescent: An update. Pediatrics 2001;107(3):562-73.
2. Greydanus DE, Patel D. Contraception in the adolescent: Preparation for the 1990's. Med Clin North Am 1990;74(5):205-24.
3. Greydanus DE. Contraception. In: Greydanus DE, Patel DR, Pratt H, Bhave S, eds. Course manual for adolescent health. Kalamazo, MI: Michigan State Univ Coll Hum Med, 2002:309-24.
4. Greydanus DE, Rimsza ME, Matytsina L. Contraception for college students. Pediatr Clin North Am 2005;52:135-61.
5. Gittes EB, Strickland JL. Contraceptive choices for chronically ill adolescents. Adolesc Med 2005;16(3):635-44.
6. Rimsza ME. Contraception in adolescents. In: Greydanus DE, Patel DR, Pratt DH, eds. Essentials of adolescent medicine. New York: McGraw-Hill Med Publ, 2005:27.
7. Klein JD, Barratt MS, Blythe MJ, et al. Contraception and adolescents. Pediatrics 2007;120:1135-48.
8. Chuang CH, Chase GA, Bensyl DM, Weisman CS. Contraceptive use by diabetic and obese women. Women's Health Issues 2005; 15:167-73.
9. Holt VL, Cushing-Haugen KL, Kaling JR. Body weight and risk of oral contraceptive failure. Obstet Gynecol 2002; 99(5 Pt 1): 820-7.
10. Holt VL, Scholes D, Wicklund KG, et al. Body mass index, weight, and oral contraceptive failure risk. Obstet Gynecol 2005;105(1):46-52.
11. Brunner Huber LR, Hogue CJ, Stein AD, et al. Body mass index and risk for oral contraceptive failure: a case-cohort study in South Carolina Ann Epidemiol 2006;16(8):637-43.
12. ACOG Practice Bulletin. Use of hormonal contraception in women with coexisting medical conditions. Clinical Management Guidelines for Obstetrician-Gynecologists. Obstet Gynecol 2006;107:1453-72.
13. Teal SB, Ginosar DM. Contraception for women with chronic medical conditions. Obstet Gynecol Clin North Am 2007;34:113-26.
14. Sicat BL. Ortho Evra, a new contraceptive patch. Pharmacotherapy 2003; 23:472-80.
15. Ortho Evra. A contraceptive patch. Med Lett 2002; 44:8.
16. Zieman M, Guillebaud J, Weisberg E, et al. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data. Fertil Steril 2002;77(2 Suppl):S13-8.
17. Sibai BM, Odlind C, Meador ML, et al. A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra). Fertil Steril 2002;77(Suppl 2):S19-26.
18. World Health Organization. Medical eligibility criteria for contraceptive use, 2ed. Geneva: WHO, Reprod Health Res, 2000.
19. World Health Organization. Medical eligibility criteria for contraceptive use, 2ed. Geneva: WHO, Reprod Health Res, 2002.
20. Vandenbrouke JP, Rosing J, Bloemenkamp KWM, et al.: Oral contraceptives and the risk of venous thrombosis. N Engl J Med 2001;344:1527-35.
21. Sheldon T. Venous thromboembolism and oral contraceptives. BMJ 2002;324:869.
22. Sidney S, Petitti DB, Soff GA, et al. Venous thromboembolic disease in users of lowestrogen combined estrogen-progestin oral contraceptives. Contraception 2004;70(1):3-10.
23. Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet 1999;353:1258- 65.
24. Kujovich JL. Hormones and pregnancy: thromboembolic risks for women. Br J Haematol 2004;126:443-54.
25. Mottram Hall Guidelines. Evidence-guided prescribing of the pill. Carnforth: Parthenon Publ, 1996.
26. Heroux K. Contraceptive choices in medically ill adolescents. Semin Reprod Med 2003;21(4):389-98.
27. Garg SK, Chase HP, Marshall G, et al. Oral contraceptives and renal and retinal complications in young women with insulin-dependent diabetes mellitus. JAMA 1994;271:1099-1102.
28. Owens K, Honebrink A. Gynecologic care of medically complicated adolescents. Pediatr Clin North Am 1999;46:631-42.
29. Freeman S. Contraceptive efficacy and patient acceptance of Lunelle. J Am Acad Nurs Pract 2002;14:241-346.
30. Keder LM. Tips for clinicians: New developments in contraception. J Pediatr Adolesc Gynecol 2002;15:179-81.
31. Trussell J, Ellertson C, Steward F, et al. The role of emergency contraception. Am J Obstet Gynecol 2004;190(Suppl 4):S30-8.
32. Emergency contraception OTC. Med Lett 2004;46:10-11.
33. Mulders TM, Dieben TO, Bennick HJ. Ovarian function with a novel combined contraceptive vaginal ring. Hum Reprod 2002; 17:2594-9.
34. Murphy NA, Elias ER. Council on children with disabilities. Sexuality of children and adolescents with developmental disabilities. Pediatrics 2006;118:398-403.
35. Glasier A. Implantable contraceptives for women: effectiveness, discontinuation rates, return of fertility, and outcome of pregnancies. Contraception 2002;65:29-37.
36. Huber J, Wenzl R. Pharmacokinetics of Implanon: an integrated analysis. Contraception 1998;58(6 Suppl):85S-90.
37. Arias RD. Compelling reasons for recommending IUDs to any woman of reproductivde age. Int J Fertil 2002;47:87-95.
38. A progestin-releasing intrauterine device for long-term contraception. Med Lett 2001;43:7-8.
39. Baldaszti E, Wimmer-Puchinger B, Loschke K. Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study. Contraception 2003;67:87-91.
40. Mansour D. Implications of the growing obesity epidemic on contraception and reproductive health. J Fam Plann Reprod Health Care 2004;30(4):209-11.